September 1, 2026 Experience Coherus Oncology $50 million at-the-market offering We advised the sales agent on the offering
September 1, 2026 Experience Moderna $3 billion convertible notes offering and capped call transactions We advised the initial purchasers on the offering
August 31, 2026 Experience Jazz Pharmaceuticals $1.25 billion exchangeable senior notes offering We advised the initial purchasers on the offering
August 27, 2026 Experience Bank of Montreal launch of MicroSectors 3× Long MANGOS+ ex Private Companies ETNs We advised Bank of Montreal on the launch of a new series of ETNs
August 26, 2026 Experience Banco Santander $2 billion notes offering We advised Banco Santander on the offering
August 26, 2026 Experience First Eagle Investments $7 billion sale to Victory Capital We are advising First Eagle Investments’ management on the transaction
August 26, 2026 Experience Immatics $172.5 million follow-on offering We advised Immatics on the offering
August 25, 2026 Experience McKesson $2.25 billion acquisition of Precision Medicine Group We are advising McKesson on the transaction
August 25, 2026 Experience Aveanna $203 million secondary offering We advised the underwriters on the offering
August 24, 2026 Experience Londian Wason $94.3 million IPO We advised Londian Wason on its IPO and NYSE listing